|Research & Innovation|
The Company’s mission statement is:
Nanomedicine is a wide field ranging from in-vivo and in-vitro diagnostics to therapy involving targeted drug delivery and regenerative medicine. It produces new tools and methods that advance significantly existing conservative practices and it will significantly change the course of treating life threatening diseases. Research and development in nanomedicine is expected to offer a pool of novel products which will improve the health of patients.
BL Nanobiomed P.C. is a nanomedical company that focuses on the development of novel drug delivery nanosystems, nanoparticles and on the development of high-value nanomaterials for implants in order to overcome the drawbacks of the existing implants.
Our core R&D activities entail the design and development of innovative drug delivery nanosystems and nanoplatforms for a wide range of implants and biomedical devices (e.g. cardiovascular, orthopedic, surgical, neurological implants, lens, patches, etc) for controllable, targeted and sustainable drug release at the diseased site.